Penserra Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-280
| Closed | -$75K | – | 1482 |
|
|
2021
Q3 | $75K | Buy |
280
+3
| +1% | +$804 | ﹤0.01% | 920 |
|
|
2021
Q2 | $71K | Buy |
277
+2
| +0.7% | +$513 | ﹤0.01% | 894 |
|
|
2021
Q1 | $82K | Sell |
275
-1
| -0.4% | -$298 | ﹤0.01% | 719 |
|
|
2020
Q4 | $70K | Buy |
276
+174
| +171% | +$44.1K | ﹤0.01% | 641 |
|
|
2020
Q3 | $25K | Buy |
+102
| New | +$25K | ﹤0.01% | 710 |
|
|
2018
Q4 | – | Sell |
-56
| Closed | -$51K | – | 734 |
|
|
2018
Q3 | $51K | Sell |
56
-1,519
| -96% | -$1.38M | ﹤0.01% | 534 |
|
|
2018
Q2 | $1.15M | Buy |
+1,575
| New | +$1.15M | 0.07% | 190 |
|